2,345
Participants
Start Date
February 28, 2017
Primary Completion Date
June 30, 2030
Study Completion Date
June 30, 2030
Data Management and Monitoring
"The Coordinating and Data Management Center (CDMC) at MD Anderson Cancer Center responsible for monitoring protocol and regulatory compliance for consortium. CDMC responsible for maintaining and tracking IRB approval and regulatory documents from each site throughout the life of the study.~* Study participants will complete questionnaires at baseline and during yearly follow-up. In the event a participant does not complete all or part of the patient or coordinator questionnaire, the study coordinator will complete questions via medical record review (e.g., demographics and family history) or via a telephone interview.~* Biospecimen collection: blood, urine, saliva, stool. Biospecimens will be collected and processed in accordance with the CPDPC specimen collection procedures.~* EUS or EGD with pancreatic fluid collection~* imaging studies performed at baseline and at follow-up.~ * IV contrast-enhanced MRI and MRCP with secretin~ * IV contrast-enhanced CT Scan abdomen"
RECRUITING
University of Texas MD Anderson Cancer Center, Houston
Collaborators (1)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
National Institutes of Health (NIH)
NIH
University of Minnesota
OTHER
Ohio State University
OTHER
Baylor College of Medicine
OTHER
Indiana University
OTHER
University of Florida
OTHER
Cedars-Sinai Medical Center
OTHER
Stanford University
OTHER
Mayo Clinic
OTHER
University of Pittsburgh Medical Center
OTHER
Kaiser Permanente
OTHER
M.D. Anderson Cancer Center
OTHER